IMPORTANT NOTICE: The most up to date information is available on our HTML feed. To access please use the SPC links on the right hand side of the screen.
All content updates in below listings will resume by 01 April 2019.
 

ARAVA

20 Milligram Tablets

Sanofi-Aventis Deutschland GmbHEU/1/99/118/006

Main Information

Trade NameARAVA
Active SubstancesLEFLUNOMIDE
Strength20 Milligram
Dosage FormTablets
Licence HolderSanofi-Aventis Deutschland GmbH
Licence NumberEU/1/99/118/006

Group Information

ATC CodeL04AA13 leflunomide

Status

Authorised/WithdrawnAuthorised
Licence Issued02/09/1999
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - HCP

Educational Materials - Patient

« Back